What funding??Good question.Majority is thinking about dilution but that is not the case (can be loan from different sources ,can be selling new shares to strategic investor etc.) and then update on China which will be bullish and then we are up.
We can be rather certain of two things:Phorm will get finding and China update will be very good.
The last RNS has been issued when the price started flying and in that situation where the funding is in negotiation the Rns was consequence so the talk to the funding party can have stable ground.